Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Insmed Incorporated

Insmed Incorporated (INSM) Stock Overview

Explore Insmed Incorporated’s financial performance, market position, analyst ratings, and future outlook.

INSM●NASDAQ
HealthcareBiotechnology
$121.16
$3.09(2.62%)
U.S. Market opens in 39h 58m

Insmed Incorporated (INSM)

Meyka AI Score

Z

Key Financials

Market Cap26.6B
P/E Ratio-43.00
EPS (TTM)$-2.82
ROE-0.83%
Fundamental Analysis

AI Price Forecasts

1 Month$127.89
3 Months$163.46
1 Year Target$160.85

INSM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Insmed Incorporated (NASDAQ: INSM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Insmed Incorporated's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of INSM on the NASDAQ shows an RSI of 64.96, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $160.85 for the NASDAQ listing.

Key metrics behind Insmed Incorporated's NASDAQ-traded stock include a P/E ratio of -43.00 and a market capitalization of 26.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of INSM on the NASDAQ.

Price Performance (NASDAQ: INSM)

1-Day Change
2.60%
5-Day Change
11.58%
1-Month Change
25.16%
3-Month Change
-4.11%
6-Month Change
2.67%
Year-to-Date (YTD) Change
-30.40%
1-Year Change
-36.56%
3-Year Change
406.86%
5-Year Change
297.18%
All-Time (Max) Change
-26.58%

Contact Information

https://www.insmed.com
908 977 9900
700 US Highway 202/206, Bridgewater, NJ, 08807

Company Facts

16,640 Employees
IPO DateJun 1, 2000
CountryUS
Actively Trading

Frequently Asked Questions